Participants 157 192 6
advanced colorectal cancer patients
Participants 615 694 7
advanced colorectal cancer (ACC) patients treated in the phase III CAIRO2 study
Participants 718 796 5
Seven hundred and fifty five previously untreated ACC patients were randomised
Participants 1116 1186 4
Seven hundred and thirty two patients were evaluable for this analysis
